Aileron Therapeutics Inc (ALRN)
3.95
+0.19
(+5.05%)
USD |
NASDAQ |
May 06, 16:00
3.95
0.00 (0.00%)
After-Hours: 16:44
Aileron Therapeutics Net Income (Quarterly): -7.339M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -7.339M |
September 30, 2023 | -1.827M |
June 30, 2023 | -1.787M |
March 31, 2023 | -4.779M |
December 31, 2022 | -4.547M |
September 30, 2022 | -6.368M |
June 30, 2022 | -7.992M |
March 31, 2022 | -8.422M |
December 31, 2021 | -6.799M |
September 30, 2021 | -6.704M |
June 30, 2021 | -5.686M |
March 31, 2021 | -6.975M |
December 31, 2020 | -4.996M |
September 30, 2020 | -5.023M |
June 30, 2020 | -4.39M |
March 31, 2020 | -6.748M |
Date | Value |
---|---|
December 31, 2019 | -7.235M |
September 30, 2019 | -7.749M |
June 30, 2019 | -7.172M |
March 31, 2019 | -7.213M |
December 31, 2018 | -7.034M |
September 30, 2018 | -7.434M |
June 30, 2018 | -9.491M |
March 31, 2018 | -7.588M |
December 31, 2017 | -6.865M |
September 30, 2017 | -6.259M |
June 30, 2017 | -4.923M |
March 31, 2017 | -4.557M |
December 31, 2016 | -4.442M |
September 30, 2016 | -4.222M |
June 30, 2016 | -5.534M |
March 31, 2016 | -3.925M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-8.422M
Minimum
Mar 2022
-1.787M
Maximum
Jun 2023
-5.923M
Average
-6.704M
Median
Sep 2021
Net Income (Quarterly) Benchmarks
EyePoint Pharmaceuticals Inc | -14.10M |
INVO Bioscience Inc | -1.995M |
Bio-Path Holdings Inc | -3.372M |
SINTX Technologies Inc | -2.321M |
NovaBay Pharmaceuticals Inc | -4.108M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 7.302M |
EPS Diluted (Quarterly) | -1.57 |
Enterprise Value | 46.11M |
Earnings Yield | -86.33% |